AstraZeneca Newswire (Page 6)

AstraZeneca Newswire (Page 6)

Comprehensive Real-Time News Feed for AstraZeneca. (Page 6)

Results 101 - 120 of 4,326 in AstraZeneca

  1. AstraZeneca flu vaccine spray fails againRead the original story w/Photo

    Jun 22, 2016 | MarketWatch

    AstraZeneca PLC's nasal-spray version of the flu vaccine failed to protect children for three years in row, prompting an expert panel to recommend that doctors stop giving it to patients. Health officials said FluMist didn't work at all against the flu strain that made most people sick last year, while the traditional flu shot worked reasonably well.

    Comment?

  2. AstraZeneca PLC Takes a $80 Million Hit as the CDC Says Flu Vaccine Flumist Does Not WorkRead the original story

    Jun 22, 2016 | BioSpace

    AstraZeneca said it would take an $80 million writedown on stocks of its flu vaccine Flumist Quadrivalent, which is sprayed into the nose, after U.S. health authorities decided they would not use the product. The U.S. Centers for Disease Control and Prevention ruled the vaccine should not be used in any setting, based on U.S. data indicating a marked drop in effectiveness in children over the last three years.

    Comment?

  3. Recent Stock Purchase June 2016Read the original story w/Photo

    Jun 22, 2016 | Seeking Alpha

    ... below other pharmaceutical dividend stocks like Merck (NYSE: MRK ), Pfizer (NYSE: PFE ), Novartis (NYSE: NVS ), AstraZeneca (NYSE: AZN ) and the like, ABBV offers a decent risk/reward at current levels. Of course, I realize that the pharmaceutical ...

    Comment?

  4. Analyzing The Wal-Mart/Visa Conflict - Bezek's Daily BriefingRead the original story w/Photo

    Jun 21, 2016 | Seeking Alpha

    ... Brexit's passage, and took advantage of the recent weakness in British shares to greatly upsize my position in Astrazeneca (NYSE: AZN ). That said, I trust the betting markets more than ephemeral changes in the polls. PredictIt, one such market, ...

    Comment?

  5. AstraZeneca plc's (AZN) Hold Rating Reiterated at Leerink SwannRead the original story w/Photo

    Jun 21, 2016 | Daily Political

    Other hedge funds have bought and sold shares of the company. Dodge & Cox increased its stake in AstraZeneca plc by 121.2% in the first quarter.

    Comment?

  6. Hutchison China MediTech (Chi-Med) Release: Savolitinib Global Phase...Read the original story

    Jun 19, 2016 | BioSpace

    Initiation of expanded Phase II trials in NSCLC triggers US$10 million milestone from AstraZeneca to Chi-Med New study builds on encouraging data from initial small Phase II studies of savolitinib in combination with Tagrisso or Iressa in c-Met-amplified NSCLC London: Monday, June 20, 2016: Hutchison China MediTech Limited today announces the initiation of a Phase II expansion of the ongoing TATTON trial to evaluate the selective c-Met inhibitor savolitinib in epidermal growth factor receptor mutant non-small cell lung cancer patients. Savolitinib has the potential to address major unmet medical needs in c-Met-driven subsets of NSCLC, a disease that is estimated to afflict approximately 1.7 million new patients annually worldwide.

    Comment?

  7. Savolitinib Global Phase II Trial Initiated in EGFR Mutant Non-Small Cell Lung CancerRead the original story w/Photo

    Jun 20, 2016 | Freshnews

    ... Hutchison MediPharma Limited ("HMP") (a 99.8% held subsidiary of Chi-Med) under the terms of the agreement with AstraZeneca PLC ("AstraZeneca") signed in December 2011. HMP and AstraZeneca are conducting Phase II studies in NSCLC with savolitinib in ...

    Comment?

  8. AstraZeneca plc (AZN) Rating Reiterated by Leerink SwannRead the original story w/Photo

    Jun 16, 2016 | AmericanBankingNews.com

    ... AZN has been the subject of several other reports. Beaufort Securities reiterated a "hold" rating on shares of AstraZeneca plc in a report on Saturday, February 20th. Deutsche Bank reiterated a "buy" rating on shares of AstraZeneca plc in a research ...

    Comment?

  9. AstraZeneca plc (AZN) Stock Rating Reaffirmed by Leerink SwannRead the original story w/Photo

    Jun 16, 2016 | AmericanBankingNews.com

    ... changes to their positions in the company. Forester Capital Management LTD increased its position in shares of AstraZeneca plc by 68.4% in the first quarter. Forester Capital Management LTD now owns 3,200 shares of the company's stock worth $109,000 ...

    Comment?

  10. AstraZeneca plc (AZN) - Research Analysts' Weekly Ratings ChangesRead the original story w/Photo

    Jun 16, 2016 | AmericanBankingNews.com

    They now have a GBX 5,000 price target on the stock. 6/14/2016 - AstraZeneca plc had its price target raised by analysts at Jefferies Group from GBX 3,900 to GBX 4,100 .

    Comment?

  11. This Week In Pharma: Manufacturing Woes For AstraZeneca's ZS-9 And Mast's EPIC DelayRead the original story w/Photo

    Jun 16, 2016 | Seeking Alpha

    This column presents questions around AstraZeneca CRL for ZZ-9 and Mast's data delay. Based on your votes for the more interesting topic, Slingshot Insights will sponsor a free expert call.

    Comment?

  12. Jefferies Group Comments on AstraZeneca plc's FY2016 EarningsRead the original story w/Photo

    Jun 15, 2016 | AmericanBankingNews.com

    Analysts at Jefferies Group reduced their FY2016 earnings per share estimates for AstraZeneca plc in a report released on Tuesday, according to Zacks Investment Research . Jefferies Group analyst J. Holford now expects that the brokerage will earn $1.99 per share for the year, down from their prior forecast of $2.01.

    Comment?

  13. Perrigo Rises Further as Takeover Rumor SwirlsRead the original story w/Photo

    Jun 15, 2016 | TheStreet.com

    ... or $16.3 billion. Of the U.K. pharmaceuticals companies with the capacity to swallow a $20 billion pillmaker, AstraZeneca ( AZN ) declined to comment, while GlaxoSmithKlein ( GSK ) did not immediately respond to a request for comment. In apparently ...

    Comment?

  14. AstraZeneca plc (AZN) Earns Outperform Rating from BNP ParibasRead the original story w/Photo

    Jun 15, 2016 | AmericanBankingNews.com

    ... other analysts also recently weighed in on the company. Shore Capital reiterated a "hold" rating on shares of AstraZeneca plc in a research report on Tuesday. Jefferies Group lifted their price objective on shares of AstraZeneca plc from GBX 3,900 ...

    Comment?

  15. AstraZeneca plc (AZN) Stock Rating Reaffirmed by Deutsche BankRead the original story w/Photo

    Jun 14, 2016 | AmericanBankingNews.com

    ... Deutsche Bank's price objective indicates a potential upside of 48.38% from the stock's current price. Shares of AstraZeneca plc (LON:AZN) traded down 1.33% on Tuesday, reaching GBX 3774.00. 3,146,536 shares of the company's stock traded hands. The ...

    Comment?

  16. Jefferies Group Increases AstraZeneca plc (AZN) Price Target to GBX 4,100Read the original story w/Photo

    Jun 14, 2016 | AmericanBankingNews.com

    ... analysts have also issued reports about the company. Beaufort Securities reaffirmed a "hold" rating on shares of AstraZeneca plc in a research report on Thursday, February 18th. Berenberg Bank set a GBX 5,200 ($73.98) price target on shares of ...

    Comment?

  17. AstraZeneca PLC Introduces AZhelps, An Innovative Savings And Support ...Read the original story

    Jun 13, 2016 | BioSpace

    AstraZeneca today announced it has expanded its patient support offerings to include AZhelps, a comprehensive and unique program that helps patients manage information across all their medications, access savings offers for their AstraZeneca medicines, and easily access healthcare support through their mobile devices and on social media channels. Lori Tierney, Vice President, Commercial Operations, at AstraZeneca said: "AstraZeneca is committed to providing affordable medicines and programs that help patients get the support they need.

    Comment?

  18. Shore Capital Reaffirms "Hold" Rating for AstraZeneca plcRead the original story w/Photo

    Jun 14, 2016 | AmericanBankingNews.com

    's stock had its "hold" rating restated by investment analysts at Shore Capital in a research report issued to clients and investors on Tuesday. Shares of AstraZeneca plc opened at 27.60 on Tuesday.

    Comment?

  19. AstraZeneca plc's (AZN) "Hold" Rating Reaffirmed at Shore CapitalRead the original story w/Photo

    Jun 14, 2016 | AmericanBankingNews.com

    AZN has been the topic of several other reports. Deutsche Bank reissued a "buy" rating on shares of AstraZeneca plc in a research report on Tuesday, February 16th.

    Comment?

  20. AstraZeneca plc (AZN) Given Hold Rating at Shore CapitalRead the original story w/Photo

    Jun 14, 2016 | AmericanBankingNews.com

    's stock had its "hold" rating restated by analysts at Shore Capital in a note issued to investors on Tuesday. AstraZeneca plc opened at 3768.0000 on Tuesday.

    Comment?